MGX vs NKE · rev $25.2M vs P/E 35, rev $46.40B
Metagenomi, Inc. Common Stock (MGX) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
MGX currently screens at market cap $44.4M. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the MGX and NKE stock pages for the full models.
Not investment advice.